Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study using human cell lines without in vivo or human clinical data.
PubMed 40251643 · doi:10.1186/s13287-025-04324-3
What was done
Extracellular vesicles (EVs) were isolated from human induced pluripotent stem cell-derived neural stem cells (hiPSC-NSCs) using chromatographic methods and characterized for size, ultrastructure, surface markers, and cellular uptake. Mature human neurons differentiated from two distinct hiPSC lines were cultured in vitro and exposed to 1 µM amyloid-beta-42 oligomers (Aβ-42o) alone or in combination with varying doses of hiPSC-NSC-EVs. Markers of neurodegeneration, oxidative stress, apoptosis (Bax, Bad, Bcl-2), mitochondrial membrane potential, autophagy, and tau phosphorylation were analyzed using one-way ANOVA with Newman-Keuls post hoc tests.
What was found
Exposure to 1 µM Aβ-42o alone induced neurodegeneration, elevated reactive oxygen species (ROS), mitochondrial superoxide, malondialdehyde (MDA), protein carbonyls, Bax, Bad, and phosphorylated tau, while reducing Bcl-2, mitochondrial membrane potential, and autophagy proteins. Addition of hiPSC-NSC-EVs at an optimal dose (6 × 10⁹ EVs) significantly attenuated neurodegeneration, reduced oxidative stress markers, normalized apoptotic and autophagy protein expression, preserved mitochondrial integrity, and decreased tau phosphorylation. Exact percentage changes, confidence intervals, and p-values were not provided in the abstract.
Why it matters
This study provides mechanistic in vitro evidence that neural stem cell-derived extracellular vesicles can protect human neurons against key pathological hallmarks of Alzheimer's disease, including amyloid-driven oxidative stress, mitochondrial failure, and tau phosphorylation.
Limits
This is strictly an in vitro cell culture experiment and does not establish in vivo efficacy, blood-brain barrier permeability, or clinical safety. Replicate counts and exact numerical effect sizes are not reported in the abstract.
Cited by
- supports Beta-amyloid triggers both the pathological phosphorylation of tau protein and the production of reactive oxygen species in the brain.